Skip to content

Tag: polio

Published on Leave a comment on Information, Knowledge, and Wisdom

I regularly read Ron Charles's Washington Post Friday Book Club newsletter, always chock full of interesting topics and writers I haven't yet explored. This Friday he included a quote from controversial (accused of plagiarism) Turkish author and activist Elif Shafak

“... we are living in a world in which there is way too much information, but little knowledge and even less wisdom.… As we scroll up and down, more out of habit than out of anything else, we have no time to process what we see. No time to absorb or reflect or feel. Hyper-information gives us the illusion of knowledge. For true knowledge to be attained we need to slow down. We need cultural spaces, literary festivals, an open and honest intellectual exchange.”

This blog is my attempt to machete a trail through all the various forms of information and provide some bridge to knowledge and wisdom by providing links to reliable original sources. Speaking of which, we are now in the midst of ID Week, probably the most prestigious annual infectious diseases research conference, and many of my regular ID feeds are filled with reports of presentations. However, I virtually never include these reports in this blog, because there is no way via these abstracts to look for potential flaws or limitations in the research, and it is well known that research meeting presentation findings often change dramatically by the time they are published in a peer-reviewed journal, if they are ever published at all.

WRIS

Still pretty quiet on the Winter Respiratory Infection Season, with some hints of beginnings of influenza and RSV increasing. Perhaps the only item of interest is an increase in Mycoplasma pneumoniae activity, probably just a regular wave that tends to happen with this pathogen, though delayed somewhat due to pandemic mitigation strategies. It's not a reportable disease, so it's hard to find good data on incidence over time. As most providers know, this is a self-limited illness that produces generally mild illness (so-called walking pneumonia) and usually not worth diagnosing or treating. Because of its self-limited nature, it's been difficult to demonstrate any benefit of antibiotic treatment compared to placebo, and I doubt we'll see any placebo-controlled randomized trials in the near future.

Compared to last winter, CDC is predicting a 54% chance of a similar combined peak of respiratory illnesses, with a 28% chance of a lower peak and 18% chance of a higher peak.

Infectious Complications of Hurricanes

These tend to get less coverage than do the more obvious loss of life and property destruction occurring immediately during a natural disaster, but the Florida Department of Health is now reporting on a surge in cases of necrotizing fasciitis due to Vibrio vulnificus, a known salt and brackish water pathogen. Here are the numbers:

As a reminder, individuals with immunodeficiencies, but also particularly including chronic liver or renal disease, are at high risk for V. vulnificus complications. CDC has a good summary.

Conjunctivitis

Researchers in Colorado looked at about 200 children with acute conjunctivitis compared to a similar number of children who were either healthy or had URI without conjunctival involvement. Long story short, they found no benefit of ophthalmic ointment treatment, but did see a 20% incidence of antibiotic side effects. The study itself didn't replicate real-world situations for providers; for example, they employed broad spectrum PCR testing looking for a large number of bacteria and viruses. The study doesn't give us much direction for practical approaches to this problem but does serve as a reminder to limit topical and other antibiotic use in acute conjunctivitis in children,

Outpatient Infant Botulism?

I would never have thought of this, I've only been called for hospitalized children with infant botulism. It turns out, though, that there are rare instances of milder disease managed as outpatients. A team reviewing the California Department of Public Health data from 1976 - 2021 found 17 of 4372 cases (0.4%) were outpatients. (Note that California cases account for about 1/3 of all US infant botulism cases.) Here's the breakdown of clinical findings.

The median age at onset of symptoms was 20 weeks, with a range of 6 - 55 weeks. Only 1 child had been exposed to honey.

Polio Updates

The second round of novel oral polio type 2 vaccinations have begun in Gaza, though I haven't heard much about ceasefires to help facilitate this critical second round. Meanwhile, this week the Global Polio Elimination Initiative had to bow to reality and revise plans and timeline for polio elimination worldwide. Now, the end of 2027 is the target for elimination of wild poliovirus infections, with end of 2029 for elimination of type 2 vaccine-derived polio. This will take significantly more funding, and the greater the risk of prolonged or new wars the less likely these targets will be achieved.

The DIKW Pyramid

I'm accustomed to using the evidence-based medicine pyramid for hierarchies of study design in medicine, but in researching Dr. Shafak's quote about wisdom I happened onto the Data, Information, Knowledge, and Wisdom pyramid. It doesn't appear to incorporate anything about the role of false or misleading data, so I'm not sure if it is a helpful model in our era. As artificial intelligence becomes more entrenched (it's impossible to remove that view from Google Chrome!), we need to be even more vigilant about our data sources.

HAL 9000 looks a lot like my doorbell. Yikes!

Published on Leave a comment on One More Time This Summer

Summer is supposed to be the slowest season in my line of work, but it doesn't seem like it. I've had trouble keeping up with everything, including some old news that I just found out about today. Maurice Williams died on August 5. If that name doesn't ring a bell, stay tuned. Here's what's up for this last post of the summer.

Mpox

It looks like we can add Gabon to the list of countries with exported mpox, this in a 30-year-old man who had stayed in Uganda for 2 weeks. The notice doesn't state whether or not this is clade I, but given that it appears to have been acquired in Uganda there is a good chance that it is. The latest WHO news was posted on August 22, the same day we heard from the CDC about the US response.

By no means is this the next pandemic, but we are seeing global spread of the clade I strain via travelers. Most important is ensuring affected African countries receive adequate vaccine supplies soon. In the US, persons in high risk groups also should be vaccinated.

Measles Check-In

Oregon is the latest state in the measles outbreak spotlight. Nationally the cases are percolating along at a steady rate.

West Nile Virus

In my post last July 28, I was halfway kidding about waiting for symptoms of West Nile virus after all my mosquito bites. West Nile is in "full swing" in Europe currently. Now I see in today's Washington Post that Tony Fauci is back home after a 6-day hospitalization for West Nile infection. Although he is 83 years of age, that's a long hospitalization and I hope he didn't have serious neurologic or other complications. I wish him a speedy recovery.

A little trivia piece I discovered years ago, did you know West Nile virus was tried as a cancer treatment in the early 1950's? Research on using flaviviruses as oncolytic agents continues. Unfortunately the lead investigator of that 50's study is mostly remembered for a serious ethical breach, injecting tumor cells into prisoners to study tumor immunology.

Timing is Everything

I have a complicated plan for how I'm going to time when I get my flu and covid vaccines in the coming weeks, based on travel plans and guessing about peak flu season. At my age, waning immunity following vaccination could be clinically significant.

This brings me to an interesting study in the BMJ trying to define optimal timing for influenza vaccination in young children. It utilized data from an administrative database in the US for timing of vaccination of over 800,000 children ages 2-5 years during several flu seasons. Bottom line, it looked like October was optimal. I wouldn't necessarily alter plans based on this study; every flu season has slightly different timing. It's probably a better plan to just vaccinate when you can, whether it be at regular checkups or flu vaccine events on evenings and weekends.

Holding My Breath on Polio

I'm still hoping polio doesn't break loose in Gaza, but I'd be more hopeful if vaccine could be distributed there. WHO has full plans in place to distribute the relatively new novel oral polio vaccine type 2 (nOPV2) to about 640,000 children under 10 years of age in 2 campaigns separated by a month. Wastewater monitoring suggests this is the strain that caused the case recently detected in a child in Gaza; we're still waiting for confirmation from a regional lab in Lebanon. Now we just need an effective ceasefire to allow this and other humanitarian aid to be implemented.

Covid

The big news was the not surprising FDA approval and emergency use authorization of the KP.2-based mRNA vaccines from Pfizer and Moderna. Novavax approval is still pending due to a longer manufacturing process. As I've said many times, if one looks at the level of individuals, it's pretty clear that vaccination benefits outweigh risks for every age group. New interim recommendations are available from the CDC.

Here's a quick look at a few disease activity indicators over the past year:

Wastewater hasn't changed much nationally.

Regionally, only the Northeast seems to be rising, though still lower than most other regions.

We'll see what happens with covid (and measles) now that schools are starting back again.

In the midst of all this, we have a new study on long covid in children. It was a multicenter prospective cohort study of about 900 younger children and 4500 adolescents, most with covid infection but some not infected who served as controls. The report is loaded with data and complexities; I'm sure everyone in the field is looking it over closely.

It's tough to summarize the findings succinctly, but perhaps you can enlarge the figure below to see details. The darker color shades are the more prominent symptoms in each cluster. Clustering of types of symptoms varied between adolescents (12-17 years) and school-age children (6-11 years). I'm very happy to see this type of analysis; it is possible that different clusters have different pathogenetic mechanisms suggesting different treatment approaches. Clusters in the younger children were in the neurocognitive, pain, and GI domains, whereas loss of smell or taste, pain, and fatigue/malaise were highlighted for the adolescents.

This study won't change clinical practice immediately, but it is a major step forward in providing a framework to base treatment studies.

"No Good Songs Ever Came Out of the 1950s"

That probably inaccurate quote, heard when I switched my car's Sirius/XM to the 50's station, came from a musically-inclined and knowledgeable friend of mine. I'm pretty sure he uttered it just to get a rise out of me, which it did. IMHO, the 50's produced a lot of good songs and shouldn't be remembered just for some wacky West Nile virus studies.

The title of this week's post is a nod to Maurice Williams who wrote the song "Stay" in my birth year, 1953, but then put it on the shelf until he recorded it with the Zodiacs in 1959. It came out in 1960 and was a big hit at just 90 seconds in length. You may be more familiar with it from the 1977 cover with slightly altered lyrics by Jackson Browne, Rosemary Butler, and David Lindley (and the 9-minute mini-medley with "The Load Out") or from the 1987 movie "Dirty Dancing" that used the Williams original. Regardless of which of the couple dozen versions I listen to, this is one of those songs that always brings a smile to my face.

2

Published on 2 Comments on “There never was a good war or a bad peace.”

This quote from a Benjamin Franklin letter written 241 years ago still rings true. It's not hard to list bad traits of war, but I find that sometimes we overlook war's contribution to infectious disease outbreaks. Now we're seeing yet another example of this that could expand if not controlled.

Last week revealed a bundle of things to mention, I've tried to trim the list as best I could.

Oropouche HAN

Now the CDC has jumped on the Oropouche virus bandwagon with a new alert via the Health Alert Network. Most useful to front line healthcare providers is an approach for when to consider Oropouche infection more likely:

  • Consider Oropouche virus infection in a patient who has been in an area with documented or suspected Oropouche virus circulation within 2 weeks of initial symptom onset (as patients may experience recurrent symptoms), and the following:
    • Abrupt onset of reported fever, headache, and one or more of the following: myalgia, arthralgia, photophobia, retroorbital/eye pain, or signs and symptoms of neuroinvasive disease (e.g., stiff neck, altered mental status, seizures, limb weakness, or cerebrospinal fluid pleocytosis); AND
    • No respiratory symptoms (e.g., cough, rhinorrhea, shortness of breath); AND
    • Tested negative for other possible diseases, in particular dengue. If strong suspicion of Oropouche virus disease exists based on the patient’s clinical features and history of travel to an area with virus circulation, do not wait for negative testing for other infections before contacting your state, tribal, local, or territorial health department.

As I've said previously, it's a clinical syndrome similar to dengue or chikungunya; note the absence of prominent respiratory symptoms. Cuba and Brazil travel has been associated with imported Oropouche in other countries; the disease is also experiencing a rise in Colombia, Peru, and Bolivia.

Mpox

Similarly, we now have mpox reported from Sweden in a traveler returning from an area of Africa where clade I disease has been active. Details are scant, but it was certainly only a matter of time before this happened. Clade I seems to have a higher mortality rate than the more common clade II variant, but it's hard to get precise numbers, much less whether anything is different about the clade Ib variant now being seen. Transmission epidemiology seems to be slightly different than the clade II epidemic of a couple years ago which stemmed primarily from men who have sex with men. In this year's clade I iteration, infections also are being spread by heterosexual encounters, usually via sex workers, and also within households. Young children and pregnant women are at highest risk for complications including fatal outcomes. Like most sexually transmitted infections, public health measures are hindered by infected people not being willing to disclose their sexual contacts. In the Democratic Republic of Congo, the epicenter of the clade I outbreak, homosexuality is not officially illegal but societal norms in the DRC are not favorable to LGBT individuals.

Effective mpox vaccines exist for preventive measures, but a recent press release from the NIH had discouraging news about antiviral therapy. Tecovirimat, aka TPOXX, had been useful in clade II disease. Now, in a placebo-controlled randomized trial of almost 600 mpox-infected subjects in the DRC, tecovirimat outcomes for mortality and for time to improvement were the same as with placebo recipients. I'd like to see the actual study results, but I tend to trust NIH press releases more than most others. CDC has a nice update and map.

Parvovirus B19 Alert

Parvo B19 infection isn't a notifiable disease in the US, so if concern has arisen it usually means something dramatic is going on. This week CDC issued a HAN notice about this infection. The disease is well known to pediatric healthcare providers and to many parents as erythema infectiosum or fifth disease. It's a minor illness unless a pregnant person is infected, with subsequent risk of miscarriage or severe fetal anemia and non-immune hydrops fetalis. Individuals with chronic hemolytic conditions are at risk for aplastic crisis and severe anemia, and immunocompromised people have higher risk of complications. Read more if you need a refresher.

Is It Time for Universal Screening for Congenital CMV?

Last week's MMWR reported on the first 12 months' experience with Minnesota's universal newborn screening program for cCMV; it began in February 2023. 184 of 60,115 (0.31%) newborns screened on a dried blood spot had positive CMV results. Note that screening dried blood spots is less sensitive than other methods; 3 infants with cCMV with negative blood spot results and were picked up by other means. Buried in the report was the interesting finding that of 11 infants with permanent hearing loss, 4 passed their hearing screening test as newborns. Clearly we need more than universal hearing screening to identify at-risk infants. I look forward to further outcome data on Minnesota's program.

Dinner at the Sick Restaurant (apologies to Anne Tyler)

I like to think of myself as an adventuresome diner, but probably I would have drawn the line at these 2 delicacies I found at ProMED, the listserv I've used for decades.

Chicken liver sashimi is a new one on me, but now linked to an outbreak of campylobacteriosis in Japan. (You'll need Google translate for this one.) Perhaps slightly less disgusting is the idea of smoked non-eviscerated fish. Recent testing found a commercial product potentially contaminated with botulinum spores; thankfully no clinical cases have been reported. I've eaten sardines from a can. They also are non-eviscerated, but apparently the fish reported this week were capelin and exceeded the length allowable for packaging non-eviscerated fish. The product was produced and distributed by a company in Florida.

Covid

Meanwhile, let's not forget about our old friend. National wastewater levels are still up.

Levels might be tapering off in some parts of the country.

Meanwhile, clinical indicators suggest we're going to be seeing increasing cases the next few weeks at least. Here's an example with percent test positivity from the same link as above. It's a little higher than it was a year ago, though it's difficult to compare time periods since different factors now drive test-seeking behavior.

Meanwhile, if we can believe news reports (the FDA can't disclose approvals ahead of time), the new KP.2 variant-based mRNA covid vaccines should be available later this week. The Novavax vaccine presumably will be ready a little later. Timing for when to get the new vaccine should be based on individual considerations, including immunocompromised state, travel plans, and other factors. However, trying to predict the amount of covid activity over the coming months is only slightly better informed than a roll of the dice. Here's the current forecast from CDC.

Polio in Gaza

Not that it's unexpected, but a case of polio has been reported in a 10-month-old child in Gaza. This child would have been born just near the start of the new war and presumably was never immunized. Breakdowns in the health system as well as with clean water and sanitation are ideal for a reappearance of polio; it hasn't been seen in Gaza in 25 years. The UN has called for a "polio pause" to allow vaccine distribution. I try to avoid political statements in this blog, and I won't change that now, but I think my old friend Ben Franklin had it right about war.

Batesian Mimicry

To end on a lighter note, when I first saw this term I immediately thought of Norman Bates and "Psycho," perhaps Hitchcock's most famous movie. But no, it's not (spoiler alert) Norman mimicking his mother. This refers to Henry Lewis Bates' 1862 publication on butterflies in the Amazon. For an easier read, try this Wikipedia page. It explains my astonished update in last week's post that the mysterious black butterfly in our garden was in fact a dark variant of the easily recognized tiger swallowtail. Apparently it is an example of Batesian mimicry whereby a vulnerable butterfly species develops the ability to mimic a less desirable (to predators) butterfly. In this case, the tiger swallowtail mimics the unpalatable and toxic pipevine swallowtail. I mentioned last week that I had probably forgotten a lot about what I learned about butterflies in my childhood. I certainly don't remember anything about Batesian mimicry or dark tiger swallowtails. Needless to say, I've been down a rabbit hole all week about this. When I went back to my 3 texts on butterflies, all mentioned the black variant in the tiger swallowtail section but not in the sections on black-colored swallowtails where I was looking. As you can see below taken from "Mimicry and the Swallowtails," they are very different but in fact have subtle similarities that escaped me.

Published on Leave a comment on Backtracking

My long-suffering (try putting up with me for 40+ years) wife, a retired general pediatrician, thought my posting about the FDA VRBPAC meeting was a bit too detailed for front-line healthcare providers. Reading it again, she's right, but of course I'll push back a little bit given that FDA has backtracked on the committee's recommendation. First, a few other updates.

Wild-type Polio Update

Thankfully we haven't had any recent polio appearances in the US, but it's a bit discouraging to see what's going on worldwide. The Global Polio Eradication Initiative reported 1 case of wild-type polio in each of 2 countries, Afghanistan and Pakistan. Here's the complete list for the week which includes vaccine-derived cases and environmental sampling as well:

  • Afghanistan: one WPV1 case
  • Pakistan: one WPV1 case and 20 positive environmental samples
  • Côte d’Ivoire: three cVDPV2-positive environmental samples
  • DR Congo: one cVDPV1 case
  • Ghana: one cVDPV2-positive environmental sample
  • Liberia: four cVDPV2-positive environmental samples
  • Niger: one cVDPV2-positive environmental sample
  • Sierra Leone: six cVDPV2-positive environmental samples
  • South Sudan: one cVDPV2 case
  • Yemen: three cVDPV2 cases

Remember that paralytic polio cases represent only the tip of the iceberg for polio infections; the vast majority of infections are asymptomatic, with a few percent manifesting as nonspecific febrile illnesses. Paralytic polio cases comprise less than 1% of infections. So, the appearance of 1 case can imply that at least 100 more infections were present in an area.

Can Infants Spread C diff in Households?

Asymptomatic Clostridioides difficile carriage is common in infants, and the organism seldom causes illness under 2 years of age. That's why you don't want to test for C diff in younger children. An interesting new study suggests, but by no means proves, that these asymptomatic carriers might be the source of household spread which could include spread to more vulnerable individuals.

Thirty families were recruited at their child's 4-month checkup to participate in this longitudinal study where participants mailed soiled infant diapers every 2 weeks to the study site, until the infants reached 8-9 months of age. Rectal swabs from mothers, and sometimes from fathers, were mailed at the same time but in separately sealed containers. (Sorry, but I couldn't help but wonder if the mail carriers had to put up with some unusual package odors!) The specimens were tested for C diff and positive samples were strain-typed and tested for toxin production.

Probably the researchers would have needed to perform more frequent sampling to prove the directionality of transmission, i.e. infant to adult or vice-versa, but they did note that the adults, compared to the infants, seldom were the initial positive carriers in these families. Sharing of C diff strains in the families was common and more often implicated infant to adult directionality. C diff prevalence in infants was 50.0-71.4%, including nontoxigenic strains, while maternal positivity was 20.0-40.0% and fathers were 20.0-37.5% positive. None of the infants or parents developed symptoms.

Something to keep in mind, but please don't start testing infants for C diff.

Misinformation Tracking

A recent article tried to look at patterns of misinformation and flagged content on Facebook. Unfortunately subscription is required for full article access, but the abstract is an accurate summary. Based on numbers of pageviews, the authors felt that unflagged content on Facebook was more likely to be influential.

The authors used a complicated (to me) combination of crowd-sourcing and machine learning to derive estimates of vaccine hesitancy and matching to pageviews. They concluded "...We estimate that the impact of unflagged content that nonetheless encouraged vaccine skepticism was 46-fold greater than that of misinformation flagged by fact-checkers." This unflagged content predominantly consisted of real facts, e.g. rare deaths following vaccination, that then were misinterpreted by viewers as the vaccine causing the death rather than within the expected death rate based on the general population, regardless of vaccination status. A classic misinterpretation due to lack of a control group!

Along the same lines, I noted with sadness that the Stanford Internet Observatory that tracks misinformation is shutting down, in large part due to lawsuits and online attacks received by staffers. Enough said.

The Flu Front

Not to be overly concerned, but a brief CDC report demonstrated spread of neuraminidase mutations in influenza A H1N1 strains in the US, showing reduced susceptibility to oseltamivir. We'll hope these don't become more common.

On the positive side, a NEJM article demonstrated that heat readily inactivates the current influenza A H5N1 strains showing up in cows' milk. I didn't see any earth-shattering news on H5N1 in the past week, but I happened upon the AAP Red Book's outbreak pages for the topic and really liked their bullet summary for current status in different populations:

People: 3 cases (in 2024)
Person-to-person spread: None
Current public health risk: Low
Dairy Cows: Ongoing multi-state outbreak
Wild Birds: Widespread
Poultry Flocks: Sporadic outbreaks
Mammals: Sporadic infections

Apparently these outbreak pages are free to the general public, so check it out. (IMHO every pediatric healthcare provider should have a Red Book subscription, included in AAP membership.)

Covid Vaccine Backtracking

Initially following the FDA VRBPAC meeting on June 5, FDA recommended that the JN.1 covid strain be utilized in the next iteration of covid vaccines. On June 13 they amended this, stating that "if feasible" the KP.2 subvariant should be used instead. What's going on?

After a day-long discussion, the VRBPAC members were asked to vote on whether or not to choose a monovalent JN.1-lineage strain to use in the next vaccine. The vote was unanimous in favor of this. As seen in the section of the lineage chart below, the JN.1 lineage includes that purple JN.1 strain at the left, as well as all the subvariants derived from it.

The VRBPAC vote didn't specify which of all those strains to pick. The discussion following the vote did address that, with the important concerns being whether newer subvariants like KP.2 and KP.3 might be dominant this fall and could evolve further to be more antigenically distinct than JN.1. In that scenario, a JN.1-based vaccine might be less effective. On the other hand, KP.2 might prove to be a worse choice if its derivatives became more antigenically distinct from other subvariants that might predominate in the fall. This is too tough to predict now. (I was also interested that CDC stated they aren't emphasizing research on using generative artificial intelligence as a predictive tool.)

I was monitoring the VRBPAC meeting in real time, and it was clear that Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, leaned more towards using the KP.2 subvariant, and I guess eventually this view prevailed. I'm not quite clear why the initial guidance didn't say that since I don't see any startling new information this past week. Here's the latest variant picture from the same link as above.

As always, the last 2 fortnight periods are only estimates; in the past, these estimates have been fairly accurate predictors. The 6/8/24 bar isn't that different from 5/25/24 in that KP.2, KP.3 and LB.1 seem to be trending towards dominance while JN.1 itself fades. It's important to remember that in general across the US covid activity is pretty low, with a few spots of minor uptick but nothing approaching a big surge so far.

Shifting towards the KP.2 variant as the vaccine component won't affect the Moderna and Pfizer planning, they were already working on both JN.1- and KP.2-based vaccines. However, Novavax won't be able to supply a KP.2 vaccine for another 6 months. They would however be able to have a JN.1 vaccine by fall. That "if feasible" phrase in the FDA announcement seems to leave the door open to allow Novavax to continue with JN.1 vaccine production; the company submitted an FDA application for authorization of this vaccine on June 14, the day after the new FDA announcement. I'll be interested to see how the discussion goes at the CDC ACIP meeting in a couple weeks.

The Eight Queens Puzzle

I was looking up the term backtracking to see where it came from (apparently it showed up in 1870), but instead found another use of the term in computer science, specifically computer algorithms. That led me to the eight queens puzzle.

Apparently there are 92 separate solutions to this puzzle, first published in 1848. Subsequently the puzzle was expanded to all natural numbers, the n queens puzzle, for which solutions exist for all of them except the numbers 2 and 3. The chessboard then has n rows and columns. This is a dangerous rabbit hole into which I hope I never fall.

Happy Father's Day to all you dads, granddads, step-dads, and every other iteration!

Published on Leave a comment on Red Book Renewal

The 33rd edition of the American Academy of Pediatrics' 2024-2027 Report of the Committee on Infectious Diseases, aka Red Book, arrived online (and on my doorstep) recently. This latest edition adds about 100 pages to the 32nd edition, even as many sections were combined or shortened. More than annual spring cleaning, this is a renewal effort for me that has become an enjoyable triennial task for me. Although the early pages provide a brief summary of changes (total 222) from the previous edition, I operationalize this by having the new Red Book at my side always, looking up every clinical situation I encounter in reading or in patient care. Not surprisingly, even after doing this for maybe the next year, I still won't remember everything, but I'll know when and where to look. Remember also that the Red Book advice is in many instances a set of consensus opinions that are subject to author bias, even with extensive review and editing. Nothing is etched in stone, and individual patient circumstances may require deviation from general recommendations.

In the meantime, let's look at what's been going on in pediatric infectious diseases recently; this isn't in the Red Book.

A New Look CDC Website

Our friends at CDC announced a new look to their website with a focus on reducing clutter and making access easier. After my first series of run-throughs, I think they are well on their way to that goal. It's worth your while to view their 2-minute YouTube video describing the changes.

Bird Flu News

Still no reason to increase fears of the next human pandemic, but plenty going on. The US Department of Agriculture (they should talk to their CDC colleagues about reducing website clutter and improving navigation!) updated beef safety with some new studies. First, USDA tested ground beef samples from stores in states known to have influenza A H5N1 present in cattle; all were negative by PCR, although they don't mention how many samples were tested. Second, they performed studies on cooking ground beef spiked with Highly Pathogenic Avian Influenza "surrogate" virus (they don't specify details or numbers). Cooking the burgers to medium (145 F) or well done (160 F) eliminated all live virus. Rare (120 F) cooking "substantially inactivated" the virus, whatever that means. I'm looking forward to results of another ongoing study of PCR testing of muscle samples from cows who were culled due to "systemic pathologies" which should go a long way in helping understand if there is any reasonable risk of transmission of H5N1 in raw beef.

Meanwhile, in the latest update there have been no new state detections in domestic livestock since April 24. Bird infections remain a major problem as judged from USDA's main avian influenza website.

FDA provided a little more detailed information than did USDA. They found no viable virus in 297 pasteurized dairy products tested and confirmed by egg inoculation studies which should be highly sensitive.

Things are improving, but more proactive testing, especially of asymptomatic wild and domestic animals and high-risk humans such as poultry and dairy workers, is needed to stay ahead of any epidemic trends.

MMWR Trifecta

I'm not a big horse-racing fan, though I did watch the Preakness this weekend. This week's (May 16) MMWR hit a trifecta for me in that 3 topics are worth mentioning, so here's a quick look.

Measles: We have a detailed report of the outbreak associated with the migrant shelter in Chicago, spread over February through April 2024. Here's the quick overview:

The key take-home points: 1) Most of the 57 cases occurred in unvaccinated individuals; 2) active case-finding and a mass vaccination campaign (882 residents were vaccinated) likely averted a larger disaster.

I wish we had similar reporting from the Florida public school outbreak, apparently managed very differently but we know nothing about what was done. I can still find only a March 8 update that sounds mostly like a political statement.

Clade I Mpox: This clade I outbreak continues in the Democratic Republic of Congo and, compared to the clade II strain that caused the global outbreak in 2022, this clade I seems more virulent, with higher morbidity and mortality than seen with clade II (this was known prior to this outbreak). Again, here's the big picture:

While the numbers appear to be trending downward in the latter dates on this graph, this could be due to delays in reporting.

Age distributions are alarming for pediatric healthcare providers though clearly are influenced by social factors present in the DRC and might not apply to any US cases if we do see global spread.

The Jynneos mpox vaccine is effective against both clades, and high-risk individuals in the US should be vaccinated. The newly revamped CDC mpox site is a good example of how they've improved the look and ease of navigation. Providers should access this again to be sure they have offered vaccine to those at risk.

Polio: This was an update on progress towards polio eradication and is a good news/bad news report. The good news is that wild-type polio infections appear to be decreasing over the period January 2022 to December 2023. Wild type polioviruses types 2 and 3 (WPV2 and WPV3) have been eradicated, and only WPV1 continues to circulate but just in Afghanistan and Pakistan. In 2023 there were only 12 cases of WPV1 identified, compared to 22 in 2022, a decrease even with more extensive sewage screening in 2023. The bad news is that circulating vaccine-derived polio (cVDPV) cases, from live polio vaccine, continues to be a problem. The number of cases decreased (881 in 2022 to 524 in 2023) but the number of countries affected increased from 24 to 32. The vast majority of these are cVDPV1 and cVDPV2. WHO has newer and more effective vaccination strategies to eliminate both wild and vaccine-derived strain infections, but implementation is difficult.

Books - Red and Other Colors

Regular readers of this blog know that I'm an avid reader. I'm not an avid book collector, however. I try to keep a relatively static number of books in the house, requiring donating old books to my neighborhood public library's used bookstore as I acquire new ones (my last trip to a used bookstore resulted in 11 additions to my sagging bookshelves). However, I'm now reminded that I have 3 collections that I don't recycle from my shelves.

First is the Red Book. I own all editions dating back to 1961, the 13th edition, plus the 6th edition of 1944. I've been unable to find the remaining 11 editions, probably because I'm not as adept at used bookstore searches as I am at PubMed searches. I'll keep trying. Three pediatric infectious diseases giants, Drs. Larry Pickering, Georges Peter, and Stan Shulman, wrote a nice review of Red Book history in 2013.

My other 2 non-recyclable book collections are very different. One is the Audrey/Maturin series of nautical novels by Patrick O'Brian. I also own several of his lesser works. I'm not sure why I hang on to all of those; perhaps it's because my initial attempt at reading one was quickly abandoned due to boredom. Years later I picked it up again and was hooked. My other collector fascination is the Parker noir series by Richard Stark, a pseudonym of Donald Westlake. I lack many in the series which I could easily buy as newly issued printings, but I prefer to prowl used bookstores for older copies. I haven't happened upon an old one in years, but hope springs eternal.

Unless otherwise indicated, the content and opinions expressed on this web site are those of the author(s). They are not endorsed by and do not necessarily reflect the views of the George Washington University.
Viewing Message: 1 of 1.
 Notice

This site uses cookies to offer you a better browsing experience. Visit GW’s Website Privacy Notice to learn more about how GW uses cookies.